The latest news from academia, regulators
research labs and other things of interest
Posted: December 22, 2008
Fluxion Moves into Germany and Austria with New Distribution Agreement
(Nanowerk News) Fluxion Biosciences announced today an exclusive distribution agreement with IUL Instruments GmbH. IUL, based in Königswinter, Germany, will handle sales and service in Germany and Austria of Fluxion’s BioFlux™ research tools for live cell image analysis in drug discovery.
IUL Instruments GmbH, founded in 1991, is a leading provider of scientific products to life science customers. IUL specializes in microbiology, cell biology and biotechnology applications. With a staff of more than 30 including product specialists who hold advanced scientific degrees, the company excels at understanding customer needs. IUL also offers after-sales support, training, technical service and maintenance inspections.
“IUL is a well-established company and has strong customer relationships in pharmaceutical and academic markets,” explained Mark Atlas, director of sales for Fluxion. “We are confident that the their expertise will augment the strength of our product technology to create a successful launch in Germany and Austria.”
“The distribution agreement with Fluxion complements our broad range of products in live cell imaging,” said Alexander Beljaars, managing director of IUL. “We are looking forward to bringing the BioFlux system to our customers in cell biology, vascular biology, microbiology and stem cell research.”
The Fluxion BioFlux 200 system is ideal for live cell imaging in applications such as cell adhesion and microbial biofilm studies. BioFlux 200 incorporates Fluxion’s proprietary microfluidic design to deliver an automated, reproducible system for studying live cells and biofilms under controlled-shear conditions. The system simulates in vivo physiological conditions more closely and at higher throughput than other approaches.
About Fluxion Biosciences
Fluxion Biosciences provides cellular analysis tools for use in critical life science research and drug discovery applications. Fluxion’s proprietary microfluidic platform enables precise functional analysis of individual cells in a multiplexed format. Fluxion’s systems meet the rigorous demands of life science and drug discovery scientists by providing an intuitive, easy-to-use operating system for single-cell biology. For more information about Fluxion Biosciences, visit www.fluxionbio.com.